Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dasiglucagon
dasiglucagon
Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial
BioSpace
Tue, 05/14/19 - 04:58 pm
Zealand Pharma
hypoglycemia
dasiglucagon
HypoPal
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Endpoints
Sun, 07/9/17 - 11:33 am
Zealand Pharma
IPO
NASDAQ
dasiglucagon
hypoglycemia
glepaglutide
short bowel syndrome